Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
archive
biology
biotech
boston blog main
boston top stories
cancer
crispr
crispr therapeutics
crispr-cas9
editas
editas medicine
endeavor
fundings & exits
health
intellia therapeutics
life sciences
national
national blog main
national top stories
p53
peter diamandis
research
san francisco blog main
san francisco top stories
singularity
singularity university
startups
study
tc
technology
What
cells
3
×
gene
3
×
human
3
×
editing
medicine
new
researchers
based
biopharmaceutical
called
cancer
cas
celgene
celularity
company
created
creating
crispr
defect
deliver
derived
developed
diamandis
directly
drive
edited
enable
endeavor
fears
flag
focus
founder
genetic
global
guardian
hold
institutions
key
known
lab
Language
unset
Current search:
cells
×
gene
×
human
×
@slashgear.com
2 years ago
Human proteins enable researchers to deliver medication directly to the cells
@xconomy.com
5 years ago
CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells
@techcrunch.com
6 years ago
With $250 million, Peter Diamandis’ new startup is all about taking stem cells from placentas
